TY - JOUR
T1 - Inherited chromosomally integrated human herpesvirus 6 and autoimmune connective tissue diseases
AU - Kawamura, Yoshiki
AU - Hashimoto, Takako
AU - Miura, Hiroki
AU - Kozawa, Kei
AU - Yoshikawa, Akiko
AU - Ikeda, Naomi
AU - Yatsuya, Hiroshi
AU - Yasuoka, Hidekata
AU - Yoshikawa, Tetsushi
N1 - Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/11
Y1 - 2020/11
N2 - Background: Entire genome of human herpesvirus 6 (HHV-6) that integrates into human chromosomes is called chromosomally integrated HHV-6 (ciHHV-6). Several viral infections have been suggested to be involved in autoimmune connective tissue diseases (CTDs). Reactivated HHV-6 from the integrated viral genome can induce immune responses against the virus. Thus, it is plausible that ciHHV-6 is associated with autoimmune CTDs. Objectives: We sought to determine whether the prevalence of ciHHV-6 was significantly higher in patients with autoimmune CTDs than in a healthy population. Study design: : A total of 846 peripheral blood samples collected from autoimmune CTD patients were analyzed. Since there was a large number of samples, they were pooled into 24 samples per group. Copy numbers of HHV-6 DNA were measured by real-time PCR. The threshold level for distinguishing between ciHHV-6 and active viral infection and the reliability of pooled DNA analysis were examined as initial validation experiments. Results: : The threshold level was 1.6 × 10^6 copy/mL in whole blood. The reliability of pooled DNA analysis to identify one ciHHV-6 sample among 23 HHV-6 DNA-negative samples was high. No HHV-6 DNA was detected in any of the pooled DNA samples collected from the patients. The probability of the present study including the 846 autoimmune CTD patient's samples was statistically not different with a healthy Japanese population which was 0.2 % or 0.6 %. Conclusions: There was no significant difference in the prevalence of ciHHV-6 between a healthy population and patients with autoimmune CTDs.
AB - Background: Entire genome of human herpesvirus 6 (HHV-6) that integrates into human chromosomes is called chromosomally integrated HHV-6 (ciHHV-6). Several viral infections have been suggested to be involved in autoimmune connective tissue diseases (CTDs). Reactivated HHV-6 from the integrated viral genome can induce immune responses against the virus. Thus, it is plausible that ciHHV-6 is associated with autoimmune CTDs. Objectives: We sought to determine whether the prevalence of ciHHV-6 was significantly higher in patients with autoimmune CTDs than in a healthy population. Study design: : A total of 846 peripheral blood samples collected from autoimmune CTD patients were analyzed. Since there was a large number of samples, they were pooled into 24 samples per group. Copy numbers of HHV-6 DNA were measured by real-time PCR. The threshold level for distinguishing between ciHHV-6 and active viral infection and the reliability of pooled DNA analysis were examined as initial validation experiments. Results: : The threshold level was 1.6 × 10^6 copy/mL in whole blood. The reliability of pooled DNA analysis to identify one ciHHV-6 sample among 23 HHV-6 DNA-negative samples was high. No HHV-6 DNA was detected in any of the pooled DNA samples collected from the patients. The probability of the present study including the 846 autoimmune CTD patient's samples was statistically not different with a healthy Japanese population which was 0.2 % or 0.6 %. Conclusions: There was no significant difference in the prevalence of ciHHV-6 between a healthy population and patients with autoimmune CTDs.
UR - http://www.scopus.com/inward/record.url?scp=85092222010&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092222010&partnerID=8YFLogxK
U2 - 10.1016/j.jcv.2020.104656
DO - 10.1016/j.jcv.2020.104656
M3 - Article
C2 - 33045641
AN - SCOPUS:85092222010
SN - 1386-6532
VL - 132
JO - Journal of Clinical Virology
JF - Journal of Clinical Virology
M1 - 104656
ER -